Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.

Morse MA, Balogh KK, Brendle SA, Campbell CA, Chen MX, Furze RC, Harada IL, Holyer ID, Kumar U, Lee K, Prinjha RK, Rüdiger M, Seal JT, Taylor S, Witherington J, Christensen ND.

Antiviral Res. 2018 Jun;154:158-165. doi: 10.1016/j.antiviral.2018.03.012. Epub 2018 Apr 11.

PMID:
29653131
2.

High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.

Guan J, Bywaters SM, Brendle SA, Ashley RE, Makhov AM, Conway JF, Christensen ND, Hafenstein S.

Viruses. 2017 Dec 6;9(12). pii: E374. doi: 10.3390/v9120374.

3.

Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Brendle SA, Christensen ND, Schell TD, Hu J.

Sci Rep. 2017 Dec 5;7(1):16932. doi: 10.1038/s41598-017-17089-4.

4.

Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.

Bywaters SM, Brendle SA, Tossi KP, Biryukov J, Meyers C, Christensen ND.

Viruses. 2017 Nov 10;9(11). pii: E336. doi: 10.3390/v9110336.

5.

Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Cladel NM, Budgeon LR, Cooper TK, Balogh KK, Christensen ND, Myers R, Majerciak V, Gotte D, Zheng ZM, Hu J.

J Gen Virol. 2017 Sep 25. doi: 10.1099/jgv.0.000926. [Epub ahead of print]

6.

The Mouse Papillomavirus Infection Model.

Hu J, Cladel NM, Budgeon LR, Balogh KK, Christensen ND.

Viruses. 2017 Aug 30;9(9). pii: E246. doi: 10.3390/v9090246. Review.

7.

HPV disease transmission protection and control.

Christensen ND.

Microb Cell. 2016 Sep 5;3(9):476-490. doi: 10.15698/mic2016.09.530. Review.

8.

Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site.

Guan J, Bywaters SM, Brendle SA, Ashley RE, Makhov AM, Conway JF, Christensen ND, Hafenstein S.

Structure. 2017 Feb 7;25(2):253-263. doi: 10.1016/j.str.2016.12.001. Epub 2017 Jan 5.

9.

Recent advances in preclinical model systems for papillomaviruses.

Christensen ND, Budgeon LR, Cladel NM, Hu J.

Virus Res. 2017 Mar 2;231:108-118. doi: 10.1016/j.virusres.2016.12.004. Epub 2016 Dec 9. Review.

10.

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL.

J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.

11.

Exclusion of IgD-, IgT- and IgM-positive immune cells in Ichthyophonus-induced granulomas in rainbow trout Oncorhynchus mykiss (Walbaum).

Al-Jubury A, LaPatra S, Christensen ND, Zuo S, Tafalla C, Buchmann K.

J Fish Dis. 2016 Nov;39(11):1399-1402. doi: 10.1111/jfd.12475. Epub 2016 May 2. No abstract available.

PMID:
27136045
12.

Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Hu J, Christensen ND.

Virology. 2016 Jan 15;488:73-80. doi: 10.1016/j.virol.2015.10.030. Epub 2015 Nov 21.

13.

The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.

Guan J, Bywaters SM, Brendle SA, Lee H, Ashley RE, Christensen ND, Hafenstein S.

J Virol. 2015 Dec;89(23):12108-17. doi: 10.1128/JVI.02020-15. Epub 2015 Sep 23.

14.

Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Hu J, Budgeon LR, Cladel NM, Balogh K, Myers R, Cooper TK, Christensen ND.

J Gen Virol. 2015 Dec;96(12):3554-65.

15.

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

Jagu S, Karanam B, Wang JW, Zayed H, Weghofer M, Brendle SA, Balogh KK, Tossi KP, Roden RBS, Christensen ND.

Vaccine. 2015 Oct 13;33(42):5553-5563. doi: 10.1016/j.vaccine.2015.09.005. Epub 2015 Sep 15.

16.

The Parasite Fauna of the Gyrfalcon (Falco rusticolus) in Iceland.

Christensen ND, Skirnisson K, Nielsen ÓK.

J Wildl Dis. 2015 Oct;51(4):929-33. doi: 10.7589/2015-01-022. Epub 2015 Aug 17.

PMID:
26280881
17.

Human Papillomavirus Vaccination Among Adults and Children in 5 US States.

Du P, Camacho F, McCall-Hosenfeld J, Lengerich E, Meyers CM, Christensen ND.

J Public Health Manag Pract. 2015 Nov-Dec;21(6):573-83. doi: 10.1097/PHH.0000000000000271.

18.

Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.

Guan J, Bywaters SM, Brendle SA, Lee H, Ashley RE, Makhov AM, Conway JF, Christensen ND, Hafenstein S.

Virology. 2015 Sep;483:253-63. doi: 10.1016/j.virol.2015.04.016. Epub 2015 May 19.

19.

SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation.

Yang L, Carrillo M, Wu YM, DiAngelo SL, Silveyra P, Umstead TM, Halstead ES, Davies ML, Hu S, Floros J, McCormack FX, Christensen ND, Chroneos ZC.

PLoS One. 2015 May 12;10(5):e0126576. doi: 10.1371/journal.pone.0126576. eCollection 2015.

20.

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.

Cladel NM, Budgeon LR, Balogh KK, Cooper TK, Hu J, Christensen ND.

PLoS One. 2015 Mar 24;10(3):e0120128. doi: 10.1371/journal.pone.0120128. eCollection 2015.

21.

Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.

Cozza EM, Cooper TK, Budgeon LR, Christensen ND, Schell TD.

Cancer Immunol Immunother. 2015 Mar;64(3):325-36. doi: 10.1007/s00262-014-1635-7. Epub 2014 Nov 19.

22.

A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Lee H, Brendle SA, Bywaters SM, Guan J, Ashley RE, Yoder JD, Makhov AM, Conway JF, Christensen ND, Hafenstein S.

J Virol. 2015 Jan 15;89(2):1428-38. doi: 10.1128/JVI.02898-14. Epub 2014 Nov 12.

23.

HPV binding assay to Laminin-332/integrin α6β4 on human keratinocytes.

Brendle SA, Christensen ND.

Methods Mol Biol. 2015;1249:53-66. doi: 10.1007/978-1-4939-2013-6_4.

PMID:
25348297
24.

Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C, Sample CE.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16544-9. doi: 10.1073/pnas.1400818111. Epub 2014 Oct 13.

25.

Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

Hu J, Budgeon LR, Balogh KK, Peng X, Cladel NM, Christensen ND.

Trials Vaccinol. 2014;3:134-142.

26.

High incidence of spontaneous cataracts in aging laboratory rabbits of an inbred strain.

Peng X, Roshwalb S, Cooper TK, Zimmerman H, Christensen ND.

Vet Ophthalmol. 2015 May;18(3):186-90. doi: 10.1111/vop.12203. Epub 2014 Aug 14.

27.

Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.

Christensen ND, Cladel NM, Hu J, Balogh KK.

Antiviral Res. 2014 Aug;108:148-55. doi: 10.1016/j.antiviral.2014.06.001. Epub 2014 Jun 16.

28.

Roles for human papillomavirus type 16 l1 cysteine residues 161, 229, and 379 in genome encapsidation and capsid stability.

Ryndock EJ, Conway MJ, Alam S, Gul S, Murad S, Christensen ND, Meyers C.

PLoS One. 2014 Jun 11;9(6):e99488. doi: 10.1371/journal.pone.0099488. eCollection 2014.

29.

The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection.

Berry GJ, Budgeon LR, Cooper TK, Christensen ND, Waldner H.

Eur J Immunol. 2014 Jun;44(6):1716-27. doi: 10.1002/eji.201344116. Epub 2014 Apr 29.

30.

Vaccines and immunization against human papillomavirus.

Christensen ND, Budgeon LR.

Curr Probl Dermatol. 2014;45:252-64. doi: 10.1159/000356183. Epub 2014 Mar 13.

PMID:
24643192
31.

Pathogenesis of infection by human papillomavirus.

Brendle SA, Bywaters SM, Christensen ND.

Curr Probl Dermatol. 2014;45:47-57. doi: 10.1159/000355963. Epub 2014 Mar 13. Review.

PMID:
24643177
32.

Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.

Cladel NM, Budgeon LR, Cooper TK, Balogh KK, Hu J, Christensen ND.

J Virol. 2013 Aug;87(16):9391-5. doi: 10.1128/JVI.00777-13. Epub 2013 Jun 19.

33.

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

Kwak K, Jiang R, Jagu S, Wang JW, Wang C, Christensen ND, Roden RB.

PLoS One. 2013;8(3):e60507. doi: 10.1371/journal.pone.0060507. Epub 2013 Mar 25.

34.

Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.

Cladel NM, Budgeon LR, Hu J, Balogh KK, Christensen ND.

Virology. 2013 Apr 10;438(2):70-83. doi: 10.1016/j.virol.2013.01.005. Epub 2013 Feb 20.

35.

The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.

Wexler AG, Frielle C, Berry G, Budgeon LR, Baccon J, Christensen ND, Waldner H.

J Neuroimmunol. 2013 Feb 15;255(1-2):60-9. doi: 10.1016/j.jneuroim.2012.11.004. Epub 2012 Dec 24.

PMID:
23269203
36.

Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16.

Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C.

PLoS One. 2011;6(7):e22427. doi: 10.1371/journal.pone.0022427. Epub 2011 Jul 19.

37.

Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Bowser BS, Chen HS, Conway MJ, Christensen ND, Meyers C.

Virus Res. 2011 Sep;160(1-2):246-55. doi: 10.1016/j.virusres.2011.06.024. Epub 2011 Jul 6.

38.

In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.

Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen ND, Wu Y, Song J.

Cancer Res. 2011 Jul 15;71(14):4742-7. doi: 10.1158/0008-5472.CAN-11-0359. Epub 2011 May 31.

39.

Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.

Hu J, Schell TD, Peng X, Cladel NM, Balogh KK, Christensen ND.

J Vaccines Vaccin. 2010 Aug 20;1(1). pii: 1000101.

40.

Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.

Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C.

PLoS One. 2011 Feb 8;6(2):e16405. doi: 10.1371/journal.pone.0016405.

41.

Papillomavirus capsid proteins mutually impact structure.

Chen HS, Conway MJ, Christensen ND, Alam S, Meyers C.

Virology. 2011 Apr 10;412(2):378-83. doi: 10.1016/j.virol.2011.01.018. Epub 2011 Feb 16.

42.
43.

Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58.

Brendle SA, Culp TD, Broutian TR, Christensen ND.

J Gen Virol. 2010 Jul;91(Pt 7):1834-9. doi: 10.1099/vir.0.017228-0. Epub 2010 Feb 24.

44.

Human alpha and beta papillomaviruses use different synonymous codon profiles.

Cladel NM, Bertotto A, Christensen ND.

Virus Genes. 2010 Jun;40(3):329-40. doi: 10.1007/s11262-010-0451-1. Epub 2010 Feb 16.

45.

A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.

Chentoufi AA, Dasgupta G, Christensen ND, Hu J, Choudhury ZS, Azeem A, Jester JV, Nesburn AB, Wechsler SL, BenMohamed L.

J Immunol. 2010 Mar 1;184(5):2561-71. doi: 10.4049/jimmunol.0902322. Epub 2010 Feb 1.

46.

Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model.

Cladel NM, Hu J, Balogh KK, Christensen ND.

J Virol Methods. 2010 Apr;165(1):36-41. doi: 10.1016/j.jviromet.2009.12.014. Epub 2009 Dec 29.

47.

Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.

Broutian TR, Brendle SA, Christensen ND.

J Gen Virol. 2010 Feb;91(Pt 2):531-40. doi: 10.1099/vir.0.012732-0. Epub 2009 Oct 21.

48.

Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines.

Conway MJ, Alam S, Christensen ND, Meyers C.

Virology. 2009 Oct 25;393(2):295-303. doi: 10.1016/j.virol.2009.08.010. Epub 2009 Sep 5.

49.

Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.

Conway MJ, Alam S, Ryndock EJ, Cruz L, Christensen ND, Roden RB, Meyers C.

J Virol. 2009 Oct;83(20):10515-26. doi: 10.1128/JVI.00731-09. Epub 2009 Aug 5.

50.

GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.

Wolfgang GH, Shibata R, Wang J, Ray AS, Wu S, Doerrfler E, Reiser H, Lee WA, Birkus G, Christensen ND, Andrei G, Snoeck R.

Antimicrob Agents Chemother. 2009 Jul;53(7):2777-84. doi: 10.1128/AAC.00103-09. Epub 2009 Apr 27.

Supplemental Content

Loading ...
Support Center